Ali Nsair, MD
@AliNsairMD
Medical Director, Heart Transplantation and Mechanical Circulatory Support, UCLA.
Interventional Cardiology.
Director, UCLA Sports Cardiology.
ID:4709767152
04-01-2016 18:19:00
993 Tweets
1,5K Followers
918 Following
Los Angeles Lakers fans, meet Olivia. Olivia was diagnosed with complex congenital heart disease before birth. After going into heart failure, she received a heart transplant. Thanks to her doctors, she is now doing well. Olivia experienced her first game as a UCLA Health Laker for a Day.
Great time with superstar UCLA Health sports medicine team for the Los Angeles Dodgers spring training physicals. Play Ball and go Los Angeles Dodgers ⚾⚾⚾
Alejandro Lemor MD, MS Sarah Gorgis, MD Brian Kolski,MD Aditya Bharadwaj Ali Nsair, MD Allison Dupont, MD Andrew M. Goldsweig, MD, MS Michael Lim Alex Truesdell Navin Kapur William W. O'Neill Chuck Simonton Mike Hacala David Wohns Matheen Khuddus Amir Kaki, MD Behnam N. Tehrani, MD Jeff Tyler Iyad Isseh إياد نبيل العسّة Henry Ford Hospital Cardiology Fellowship Dr. Faisal Rahman What’s new: early use of MCS w Impella in AMI-CS is feasible across health care systems and resulted in improvements to early hemodynamics and perfusion.
Now I have even more support for making UCLA Cardiology Fellowship IC fellows calculate CPO and do RHC for 3 am STEMI #CS patients UCLA Interventional Cardiology.
#CS management before Stenting.
Kicking off the UCLA Health State of the Art HF symposium with a tour de force talk by Dr. Fonarow on the state of art on GDMT in 2023. Implementation needed! Gregg Fonarow MD HFSA
The future of Xenotransplantation is here, great hope for patients with end stage organ failure. SECOND ❤️ ❤️ Xenotransplant in a year. The science of Xenotransplantation is evolving at rapid pace. UCLA Cardiology Fellowship Pratyaksh Srivastava, MD Negeen Shahandeh, MD Jeff Hsu, MD, PhD Gregg Fonarow MD UCLA Cardiology Fellowship
Want the latest & greatest in #HF / #OHT / #MCS / #VAD / #SHD / #Cardioonc / #CardioOb ??!
See🔥talks by Department of Medicine at UCLA Health UCLA Health experts Ali Nsair, MD Gregg Fonarow MD Negeen Shahandeh, MD Richard Shemin,MD Marcella Press MDPhD Murray Kwon, MD, MBA Jamil Aboulhosn Megan Kamath Jessica Wang Jason Bradfield, MD & more!
UCLA Cardiology Fellowship
Impressive findings
Kalyanam Shivkumar MD PhD Ali Nsair, MD
Catheter Ablation in End-Stage Heart Failure with Atrial Fibrillation | NEJM nejm.org/doi/full/10.10…
West LA VA hospital among the 10 best (lowest) for 30 day mortality after hospitalization for HF according to this report
4. VA Greater Los Angeles Healthcare System
beckershospitalreview.com/cardiology/10-…
UCLA Health Department of Medicine at UCLA Health UCLA Cardiology Fellowship Ali Nsair, MD Boback Ziaeian 🤦🏻♂️ Jeff Hsu, MD, PhD Zhaoping Li
Donor-transmitted CAD after heart transplantation may occur in as many as 1 in 5 pts but doesn't seem to affect survival in those well enough to undergo angiography within the first 3 mos post-transplant, according to new data.
tctmd.com/news/cad-donor… David Couto Mallón Rushi Parikh
Join us (in-person & virtual) for our CME accredited UCLA Health Heart Failure & Advanced Cardiovascular Therapies Symposium, Sept 23 in beautiful Marina Del Rey for latest Medical, Interventional & Surgical State of the Art Therapies. HFSA California ACC
events.medschool.ucla.edu/event/heartfai…
A special Department of Medicine at UCLA Health UCLA Health David Geffen School of Medicine at UCLA UCLA Cardiology Fellowship #bruinhearts in person graduation this yr…proud & 😢 to send off this amazing class of cardiologists & future leaders & my #cardioonc clinic fellows!
Congrats & 🙏 Karol Watson JK Han MD Justin Hayase Asim Rafique MD Gregg Fonarow MD
A new position for an #AHF #OHT fellowship UCLA Health #HF program has become available for the upcoming 2023/24 academic year. Please DM me for any Cardio fellows interested. CardioNerds UCLA Cardiology Fellowship Eric H Yang, MD Karol Watson Gregg Fonarow MD Jeff Hsu, MD, PhD The ISHLT HFSA California ACC
Euroshock trial, stopped at 35 pts. 30 day mortality occurred in 43.8% of pts in ECMO arm vs 61.1%. 1 yr mortality was 51.8% in ECMO arm vs 81.5%. Vascular & bleeding complications higher in ECMO arm. Underpowered but headed in the right direction! eurointervention.pcronline.com/article/venoar…
⏰ Last Day to Save $
Advanced registration for #ACCAthleticHeart ends TODAY
📆 June 8-10
🏛️ Washington, DC
🧑🏻🏫 In-person (limited seats!) & 👩🏽💻Virtual options
Register now to learn from #SportsCardio experts, see posters on latest research & more
👉🏼bit.ly/3n42lhu